These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 23368527)

  • 1. Antidiabetic therapy effects on bone metabolism and fracture risk.
    Montagnani A; Gonnelli S
    Diabetes Obes Metab; 2013 Sep; 15(9):784-91. PubMed ID: 23368527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diabetes and bone fragility: a dangerous liaison.
    Conti F; Wolosinska DT; Pugliese G
    Aging Clin Exp Res; 2013 Oct; 25 Suppl 1():S39-41. PubMed ID: 23907773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Thiazolidinediones and skeletal health].
    Meier C; Bodmer M; Meier CR; Kraenzlin ME
    Rev Med Suisse; 2009 Jun; 5(207):1309-10, 1312-3. PubMed ID: 19626930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of diabetes drugs on the skeleton.
    Meier C; Schwartz AV; Egger A; Lecka-Czernik B
    Bone; 2016 Jan; 82():93-100. PubMed ID: 25913633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osteoporosis and risk of fracture in patients with diabetes: an update.
    Montagnani A; Gonnelli S; Alessandri M; Nuti R
    Aging Clin Exp Res; 2011 Apr; 23(2):84-90. PubMed ID: 21743287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diabetes mellitus and osteoporosis. Effect of antidiabetic medicine on osteoporotic fracture].
    Hayakawa N; Suzuki A
    Clin Calcium; 2012 Sep; 22(9):1383-90. PubMed ID: 22932293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thiazolidinedione-induced skeletal fragility--mechanisms and implications.
    Grey A
    Diabetes Obes Metab; 2009 Apr; 11(4):275-84. PubMed ID: 18671797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of diabetes and diabetes medications on bone health.
    Gilbert MP; Pratley RE
    Endocr Rev; 2015 Apr; 36(2):194-213. PubMed ID: 25738213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone as a target of type 2 diabetes treatment.
    Lecka-Czernik B
    Curr Opin Investig Drugs; 2009 Oct; 10(10):1085-90. PubMed ID: 19777397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of diabetes and its treatments on skeletal diseases.
    Yan W; Li X
    Front Med; 2013 Mar; 7(1):81-90. PubMed ID: 23377889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetes drug pioglitazone (Actos): risk of fracture.
    Meymeh RH; Wooltorton E
    CMAJ; 2007 Sep; 177(7):723-4. PubMed ID: 17823139
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of antidiabetic treatment on bone.
    Jackuliak P; Kužma M; Payer J
    Physiol Res; 2019 Nov; 68(Suppl 2):S107-S120. PubMed ID: 31842574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Overview: derangement of bone metabolism in diabetes mellitus].
    Takeuchi Y
    Clin Calcium; 2009 Sep; 19(9):1247-55. PubMed ID: 19721195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Do thiazolidinediones harm skeletal integrity?].
    Takeuchi Y
    Clin Calcium; 2008 May; 18(5):650-5. PubMed ID: 18445884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone loss in diabetes: use of antidiabetic thiazolidinediones and secondary osteoporosis.
    Lecka-Czernik B
    Curr Osteoporos Rep; 2010 Dec; 8(4):178-84. PubMed ID: 20809203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Type 2 diabetes, thiazolidinediones: bad to the bone?
    Watts NB; D'Alessio DA
    J Clin Endocrinol Metab; 2006 Sep; 91(9):3276-8. PubMed ID: 16960122
    [No Abstract]   [Full Text] [Related]  

  • 17. What to add in with metformin in type 2 diabetes?
    Petrie JR; Adler A; Vella S
    QJM; 2011 Mar; 104(3):185-92. PubMed ID: 21156663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diabetes and bone health.
    Antonopoulou M; Bahtiyar G; Banerji MA; Sacerdote AS
    Maturitas; 2013 Nov; 76(3):253-9. PubMed ID: 23628280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of diabetes mellitus-induced bone fragility.
    Napoli N; Chandran M; Pierroz DD; Abrahamsen B; Schwartz AV; Ferrari SL;
    Nat Rev Endocrinol; 2017 Apr; 13(4):208-219. PubMed ID: 27658727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incretin based therapies: bone protective effects.
    Chakhtoura M; Azar ST
    Endocr Metab Immune Disord Drug Targets; 2013 Dec; 13(4):289-94. PubMed ID: 24138054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.